Lexaria Bioscience Corp.
LEXX
$0.60
$0.034.44%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.27M | 4.42M | 1.97M | 4.63M | 6.54M |
| Total Receivables | 42.00K | 88.00K | 368.40K | 358.10K | 331.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 458.80K | 850.60K | 1.13M | 823.30K | 850.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.77M | 5.36M | 3.47M | 5.81M | 7.72M |
|
|
|||||
| Total Current Assets | 5.77M | 5.36M | 3.47M | 5.81M | 7.72M |
| Net Property, Plant & Equipment | 334.90K | 315.60K | 334.90K | 354.20K | 383.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 318.10K | 308.10K | 307.80K | 516.40K | 506.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.00K | 64.00K | 64.00K | 64.00K | 64.00K |
| Total Assets | 6.49M | 6.05M | 4.18M | 6.74M | 8.68M |
|
|
|||||
| Total Accounts Payable | 36.20K | 1.18M | 569.80K | 597.50K | 1.28M |
| Total Accrued Expenses | 146.40K | 249.00K | 893.30K | 860.80K | 514.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.10K | 31.10K | 30.40K | 29.90K | 29.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 214.70K | 1.46M | 1.49M | 1.49M | 1.82M |
|
|
|||||
| Total Current Liabilities | 214.70K | 1.46M | 1.49M | 1.49M | 1.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.30K | 70.80K | 78.90K | 86.70K | 94.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 277.00K | 1.53M | 1.57M | 1.57M | 1.92M |
|
|
|||||
| Common Stock & APIC | 73.16M | 70.04M | 66.52M | 66.40M | 64.24M |
| Retained Earnings | -66.51M | -65.06M | -63.46M | -60.76M | -56.98M |
| Treasury Stock & Other | -55.40K | -76.10K | -70.30K | -81.10K | -118.20K |
| Total Common Equity | 6.60M | 4.91M | 2.99M | 5.55M | 7.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.60M | 4.91M | 2.99M | 5.55M | 7.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -392.20K | -389.40K | -386.90K | -385.60K | -384.00K |
| Total Equity | 6.21M | 4.52M | 2.60M | 5.17M | 6.76M |
|
|
|||||